 | • レポートコード：B-GIR08C3438 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、肝線維症治療薬の世界市場について調べ、まとめました。種類別セグメントは、ヌクレオシド、インターフェロン、その他等、用途別セグメントは、肝炎、肝線維症、その他等に区分しました。肝線維症治療薬の世界市場概観、企業動向、企業別肝線維症治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・肝線維症治療薬の市場概観 ・肝線維症治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・肝線維症治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・肝線維症治療薬の世界市場規模 ・肝線維症治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・肝線維症治療薬のアメリカ市場規模推移 ・肝線維症治療薬のカナダ市場規模推移 ・肝線維症治療薬のメキシコ市場規模推移 ・肝線維症治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・肝線維症治療薬のドイツ市場規模推移 ・肝線維症治療薬のイギリス市場規模推移 ・肝線維症治療薬のロシア市場規模推移 ・肝線維症治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・肝線維症治療薬の日本市場規模推移 ・肝線維症治療薬の中国市場規模推移 ・肝線維症治療薬の韓国市場規模推移 ・肝線維症治療薬のインド市場規模推移 ・肝線維症治療薬の東南アジア市場規模推移 ・肝線維症治療薬の南米市場分析（ブラジル、アルゼンチン等） ・肝線維症治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・肝線維症治療薬の種類別分析/販売量、売上、市場シェア（ヌクレオシド、インターフェロン、その他） ・肝線維症治療薬の用途別分析/市場規模（肝炎、肝線維症、その他） ・肝線維症治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・肝線維症治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Liver fibrosis is the scarring process that represents the liver’s response to injury. In the same way as skin and other organs heal wounds through deposition of collagen and other matrix constituents so the liver repairs injury through the deposition of new collagen.
Scope of the Report:
The classification of Liver Fibrosis Drug includes nucleoside, interferon and others, and the proportion of nucleoside type in 2018 is about 45.37%, and the proportion keeps stable trend from 2014 to 2025.Liver fibrosis drug is widely used for Hepatitis, Liver Fibrosis and Other. The most proportion of Interferon is used for hepatitis, and the proportion in 2018 is 68.37%.
North America is the largest consumption place, with a consumption market share nearly 47.09% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 25.14%.
Market competition is intense. Gilead, Biogen Idec, Merck KGaA, Bristol-Myers Squibb Company, Roche, Merck & Co., Inc and Tri-Prime are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Liver Fibrosis Drug is expected to grow at a CAGR of roughly -1.7% over the next five years, will reach 13530 million US$ in 2024, from 14710 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Liver Fibrosis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Gilead
Biogen Idec
Merck KGaA
Bristol-Myers Squibb Company
Roche
Merck & Co.
Tri-Prime
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Nucleoside
Interferon
Other
Market Segment by Applications, can be divided into
Hepatitis
Liver Fibrosis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liver Fibrosis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liver Fibrosis Drug, with price, sales, revenue and global market share of Liver Fibrosis Drug in 2017 and 2018.
Chapter 3, the Liver Fibrosis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liver Fibrosis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Liver Fibrosis Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Liver Fibrosis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Liver Fibrosis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Nucleoside
1.2.2 Interferon
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Hepatitis
1.3.2 Liver Fibrosis
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead
2.1.1 Business Overview
2.1.2 Liver Fibrosis Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gilead Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Biogen Idec
2.2.1 Business Overview
2.2.2 Liver Fibrosis Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biogen Idec Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck KGaA
2.3.1 Business Overview
2.3.2 Liver Fibrosis Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck KGaA Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb Company
2.4.1 Business Overview
2.4.2 Liver Fibrosis Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Liver Fibrosis Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck & Co.
2.6.1 Business Overview
2.6.2 Liver Fibrosis Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck & Co. Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Tri-Prime
2.7.1 Business Overview
2.7.2 Liver Fibrosis Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tri-Prime Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Liver Fibrosis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Liver Fibrosis Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Liver Fibrosis Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Liver Fibrosis Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Liver Fibrosis Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Liver Fibrosis Drug Market Analysis by Regions
4.1 Global Liver Fibrosis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Liver Fibrosis Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Liver Fibrosis Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
4.3 Europe Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
4.5 South America Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
5 North America Liver Fibrosis Drug by Country
5.1 North America Liver Fibrosis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Liver Fibrosis Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Liver Fibrosis Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
5.3 Canada Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
6 Europe Liver Fibrosis Drug by Country
6.1 Europe Liver Fibrosis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Liver Fibrosis Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Liver Fibrosis Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
6.3 UK Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
6.4 France Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
6.5 Russia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
6.6 Italy Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Liver Fibrosis Drug by Country
7.1 Asia-Pacific Liver Fibrosis Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Liver Fibrosis Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Liver Fibrosis Drug Revenue and Market Share by Country (2014-2019)
7.2 China Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
7.3 Japan Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
7.4 Korea Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
7.5 India Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
8 South America Liver Fibrosis Drug by Country
8.1 South America Liver Fibrosis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Liver Fibrosis Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Liver Fibrosis Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Liver Fibrosis Drug by Countries
9.1 Middle East and Africa Liver Fibrosis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Liver Fibrosis Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Liver Fibrosis Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
10 Global Liver Fibrosis Drug Market Segment by Type
10.1 Global Liver Fibrosis Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Liver Fibrosis Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Liver Fibrosis Drug Revenue and Market Share by Type (2014-2019)
10.2 Nucleoside Sales Growth and Price
10.2.1 Global Nucleoside Sales Growth (2014-2019)
10.2.2 Global Nucleoside Price (2014-2019)
10.3 Interferon Sales Growth and Price
10.3.1 Global Interferon Sales Growth (2014-2019)
10.3.2 Global Interferon Price (2014-2019)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2014-2019)
10.4.2 Global Other Price (2014-2019)
11 Global Liver Fibrosis Drug Market Segment by Application
11.1 Global Liver Fibrosis Drug Sales Market Share by Application (2014-2019)
11.2 Hepatitis Sales Growth (2014-2019)
11.3 Liver Fibrosis Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Liver Fibrosis Drug Market Forecast (2019-2024)
12.1 Global Liver Fibrosis Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Liver Fibrosis Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Liver Fibrosis Drug Market Forecast (2019-2024)
12.2.2 Europe Liver Fibrosis Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Liver Fibrosis Drug Market Forecast (2019-2024)
12.2.4 South America Liver Fibrosis Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Liver Fibrosis Drug Market Forecast (2019-2024)
12.3 Liver Fibrosis Drug Market Forecast by Type (2019-2024)
12.3.1 Global Liver Fibrosis Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Liver Fibrosis Drug Market Share Forecast by Type (2019-2024)
12.4 Liver Fibrosis Drug Market Forecast by Application (2019-2024)
12.4.1 Global Liver Fibrosis Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Liver Fibrosis Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Liver Fibrosis Drug Picture
Table Product Specifications of Liver Fibrosis Drug
Figure Global Sales Market Share of Liver Fibrosis Drug by Types in 2018
Table Liver Fibrosis Drug Types for Major Manufacturers
Figure Nucleoside Picture
Figure Interferon Picture
Figure Other Picture
Figure Liver Fibrosis Drug Sales Market Share by Applications in 2018
Figure Hepatitis Picture
Figure Liver Fibrosis Picture
Figure Other Picture
Figure United States Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Liver Fibrosis Drug Revenue (Value) and Growth Rate (2014-2024)
Table Gilead Basic Information, Manufacturing Base and Competitors
Table Gilead Liver Fibrosis Drug Type and Applications
Table Gilead Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Liver Fibrosis Drug Type and Applications
Table Biogen Idec Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Liver Fibrosis Drug Type and Applications
Table Merck KGaA Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Type and Applications
Table Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Liver Fibrosis Drug Type and Applications
Table Roche Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Liver Fibrosis Drug Type and Applications
Table Merck & Co. Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tri-Prime Basic Information, Manufacturing Base and Competitors
Table Tri-Prime Liver Fibrosis Drug Type and Applications
Table Tri-Prime Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Liver Fibrosis Drug Sales by Manufacturer (2017-2018)
Figure Global Liver Fibrosis Drug Sales Market Share by Manufacturer in 2017
Figure Global Liver Fibrosis Drug Sales Market Share by Manufacturer in 2018
Table Global Liver Fibrosis Drug Revenue by Manufacturer (2017-2018)
Figure Global Liver Fibrosis Drug Revenue Market Share by Manufacturer in 2017
Figure Global Liver Fibrosis Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Liver Fibrosis Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Liver Fibrosis Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Global Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table Global Liver Fibrosis Drug Sales by Regions (2014-2019)
Table Global Liver Fibrosis Drug Sales Market Share by Regions (2014-2019)
Table Global Liver Fibrosis Drug Revenue by Regions (2014-2019)
Figure Global Liver Fibrosis Drug Revenue Market Share by Regions (2014-2019)
Figure Global Liver Fibrosis Drug Revenue Market Share by Regions in 2018
Figure North America Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Europe Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure South America Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure North America Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table North America Liver Fibrosis Drug Sales by Countries (2014-2019)
Table North America Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Figure North America Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Figure North America Liver Fibrosis Drug Sales Market Share by Countries in 2018
Table North America Liver Fibrosis Drug Revenue by Countries (2014-2019)
Table North America Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure North America Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure North America Liver Fibrosis Drug Revenue Market Share by Countries in 2018
Figure United States Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Canada Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Mexico Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Europe Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table Europe Liver Fibrosis Drug Sales by Countries (2014-2019)
Table Europe Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Table Europe Liver Fibrosis Drug Revenue by Countries (2014-2019)
Figure Europe Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Liver Fibrosis Drug Revenue Market Share by Countries in 2018
Figure Germany Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure UK Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure France Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Russia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Italy Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Liver Fibrosis Drug Sales by Countries (2014-2019)
Table Asia-Pacific Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Liver Fibrosis Drug Sales Market Share by Countries 2018
Table Asia-Pacific Liver Fibrosis Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Liver Fibrosis Drug Revenue Market Share by Countries 2018
Figure China Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Japan Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Korea Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure India Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure South America Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table South America Liver Fibrosis Drug Sales by Countries (2014-2019)
Table South America Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Figure South America Liver Fibrosis Drug Sales Market Share by Countries in 2018
Table South America Liver Fibrosis Drug Revenue by Countries (2014-2019)
Table South America Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure South America Liver Fibrosis Drug Revenue Market Share by Countries in 2018
Figure Brazil Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Argentina Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Colombia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Liver Fibrosis Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Liver Fibrosis Drug Sales by Countries (2014-2019)
Table Middle East and Africa Liver Fibrosis Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Liver Fibrosis Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Liver Fibrosis Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure UAE Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Egypt Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Figure South Africa Liver Fibrosis Drug Sales and Growth Rate (2014-2019)
Table Global Liver Fibrosis Drug Sales by Type (2014-2019)
Table Global Liver Fibrosis Drug Sales Share by Type (2014-2019)
Table Global Liver Fibrosis Drug Revenue by Type (2014-2019)
Table Global Liver Fibrosis Drug Revenue Share by Type (2014-2019)
Figure Global Nucleoside Sales Growth (2014-2019)
Figure Global Nucleoside Price (2014-2019)
Figure Global Interferon Sales Growth (2014-2019)
Figure Global Interferon Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Liver Fibrosis Drug Sales by Application (2014-2019)
Table Global Liver Fibrosis Drug Sales Share by Application (2014-2019)
Figure Global Liver Fibrosis Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Liver Fibrosis Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Liver Fibrosis Drug Sales Forecast by Regions (2019-2024)
Table Global Liver Fibrosis Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Liver Fibrosis Drug Market Forecast (2019-2024)
Figure Europe Sales Liver Fibrosis Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Liver Fibrosis Drug Market Forecast (2019-2024)
Figure South America Sales Liver Fibrosis Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Liver Fibrosis Drug Market Forecast (2019-2024)
Table Global Liver Fibrosis Drug Sales Forecast by Type (2019-2024)
Table Global Liver Fibrosis Drug Market Share Forecast by Type (2019-2024)
Table Global Liver Fibrosis Drug Sales Forecast by Application (2019-2024)
Table Global Liver Fibrosis Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
肝線維症治療薬市場：世界及び中国市場分析・予測（～2024年） Liver Fibrosis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Liver Fibrosis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Liver Fibrosis Drug manufactur…- 脂肪肝疾患薬市場：世界及び中国の市場分析・予測（～2024年） Fatty Liver Disease Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Fatty Liver Disease Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fatty Liver Disease …
- 非アルコール性脂肪肝疾患（NAFLD）薬市場：世界及び中国の市場分析・予測（～2024年） Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry with a focus on the Chinese market. The report provides key statistics on t…
- 世界の肝生検市場：市場規模・現状・予測 Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.Liver biopsies may be taken percutaneously (via a needle throu…
- 肝油市場：世界及び中国市場分析・予測（～2024年） Cod Liver Oil Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cod Liver Oil industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cod Liver Oil manufacturers and is a valua…